$RXO
RXO, Inc.

2023 Q4 Form 10-Q Financial Statement

#000192956123000093 Filed on November 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $978.0M $976.0M
YoY Change -12.68% -14.24%
Cost Of Revenue $799.0M $801.0M
YoY Change -11.32% -12.27%
Gross Profit $179.0M $175.0M
YoY Change -18.26% -22.22%
Gross Profit Margin 18.3% 17.93%
Selling, General & Admin $146.0M $148.0M
YoY Change -5.81% -6.33%
% of Gross Profit 81.56% 84.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $15.00M $16.00M
YoY Change -28.57% -30.43%
% of Gross Profit 8.38% 9.14%
Operating Expenses $161.0M $148.0M
YoY Change -8.52% -6.33%
Operating Profit $18.00M $6.000M
YoY Change -58.14% -60.0%
Interest Expense -$8.000M -$8.000M
YoY Change 60.0% -900.0%
% of Operating Profit -44.44% -133.33%
Other Income/Expense, Net -$2.000M -$1.000M
YoY Change 0.0%
Pretax Income $4.000M -$3.000M
YoY Change -166.67% -120.0%
Income Tax $2.000M -$2.000M
% Of Pretax Income 50.0%
Net Earnings $2.000M -$1.000M
YoY Change -150.0% -107.69%
Net Earnings / Revenue 0.2% -0.1%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share $0.02 -$0.01
COMMON SHARES
Basic Shares Outstanding 117.0M shares 117.0M shares
Diluted Shares Outstanding 117.0M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.000M $104.0M
YoY Change -94.9% -44.39%
Cash & Equivalents $5.000M $104.0M
Short-Term Investments
Other Short-Term Assets $48.00M $45.00M
YoY Change 54.84% 73.08%
Inventory
Prepaid Expenses $22.00M
Receivables $743.0M $787.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $796.0M $936.0M
YoY Change -22.64% -23.59%
LONG-TERM ASSETS
Property, Plant & Equipment $124.0M $295.0M
YoY Change 4.2% 4.98%
Goodwill $630.0M $630.0M
YoY Change 0.0% 0.0%
Intangibles $68.00M $72.00M
YoY Change -13.92% -15.29%
Long-Term Investments
YoY Change
Other Assets $12.00M $13.00M
YoY Change -20.0% -18.75%
Total Long-Term Assets $1.029B $1.010B
YoY Change 2.69% -0.2%
TOTAL ASSETS
Total Short-Term Assets $796.0M $936.0M
Total Long-Term Assets $1.029B $1.010B
Total Assets $1.825B $1.946B
YoY Change -10.14% -13.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $414.0M $448.0M
YoY Change -17.37% -18.1%
Accrued Expenses $199.0M $221.0M
YoY Change -22.27% -22.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.000M $3.000M
YoY Change -25.0% -40.0%
Total Short-Term Liabilities $682.0M $728.0M
YoY Change -17.13% -18.02%
LONG-TERM LIABILITIES
Long-Term Debt $356.0M $451.0M
YoY Change -21.06% 7416.67%
Other Long-Term Liabilities $40.00M $37.00M
YoY Change 0.0% 2.78%
Total Long-Term Liabilities $549.0M $628.0M
YoY Change -11.59% 206.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $682.0M $728.0M
Total Long-Term Liabilities $549.0M $628.0M
Total Liabilities $1.231B $1.356B
YoY Change -14.75% 24.06%
SHAREHOLDERS EQUITY
Retained Earnings $6.000M $4.000M
YoY Change 200.0%
Common Stock $1.000M $1.000M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $594.0M $590.0M
YoY Change
Total Liabilities & Shareholders Equity $1.825B $1.946B
YoY Change -10.14% -13.01%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $2.000M -$1.000M
YoY Change -150.0% -107.69%
Depreciation, Depletion And Amortization $15.00M $16.00M
YoY Change -28.57% -30.43%
Cash From Operating Activities $19.00M $4.000M
YoY Change -75.0% -92.98%
INVESTING ACTIVITIES
Capital Expenditures $18.00M $18.00M
YoY Change 0.0% 20.0%
Acquisitions
YoY Change
Other Investing Activities -$1.000M -$1.000M
YoY Change -200.0%
Cash From Investing Activities -$19.00M -$19.00M
YoY Change 5.56% 35.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -100.0M -4.000M
YoY Change -31.03% -94.12%
NET CHANGE
Cash From Operating Activities 19.00M 4.000M
Cash From Investing Activities -19.00M -19.00M
Cash From Financing Activities -100.0M -4.000M
Net Change In Cash -100.0M -19.00M
YoY Change 14.94% -24.0%
FREE CASH FLOW
Cash From Operating Activities $19.00M $4.000M
Capital Expenditures $18.00M $18.00M
Free Cash Flow $1.000M -$14.00M
YoY Change -98.28% -133.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115163000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115163000 shares
us-gaap Net Income Loss
NetIncomeLoss
96000000 usd
us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2000000 usd
us-gaap Net Income Loss
NetIncomeLoss
96000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
65000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
9000000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-8000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
rxo Payments To Proceeds From Parent Financing Activities
PaymentsToProceedsFromParentFinancingActivities
0 usd
rxo Payments To Proceeds From Parent Financing Activities
PaymentsToProceedsFromParentFinancingActivities
39000000 usd
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
3000000 usd
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
0 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
1000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-38000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
158000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187000000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
60000000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
46000000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
1000000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
8000000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
25000000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
3000000 usd
rxo Cash Paid For Interest
CashPaidForInterest
18000000 usd
rxo Cash Paid For Interest
CashPaidForInterest
0 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
589000000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1000000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
5000000 usd
CY2023Q3 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
48000 shares
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3000000 usd
CY2023Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
0 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
590000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
587000000 usd
us-gaap Net Income Loss
NetIncomeLoss
2000000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
16000000 usd
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
702000 shares
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
13000000 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
2000000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
590000000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1199000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
13000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2000000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
3000000 usd
CY2022Q3 rxo Net Transfers To Parent
NetTransfersToParent
69000000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1144000000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1070000000 usd
us-gaap Net Income Loss
NetIncomeLoss
96000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2000000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
9000000 usd
rxo Net Transfers To Parent
NetTransfersToParent
29000000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 reportingsegment
CY2022Q4 rxo Stockholders Equity Note Spinoff Transaction Percent Of Shares Outstanding Distributed
StockholdersEquityNoteSpinoffTransactionPercentOfSharesOutstandingDistributed
1
CY2022Q4 rxo Shares Of Companys Common Stock
SharesOfCompanysCommonStock
1 shares
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
976000000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1138000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2949000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3676000000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
976000000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1138000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2949000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3676000000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
120000000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.99
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3Y
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
3000000 usd
us-gaap Restructuring Charges
RestructuringCharges
12000000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
9000000 usd
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
6000000 usd
CY2023Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
462000000 usd
CY2023Q3 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
454000000 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
464000000 usd
CY2022Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
455000000 usd
CY2023Q3 us-gaap Debt Current
DebtCurrent
3000000 usd
CY2023Q3 us-gaap Debt Current
DebtCurrent
3000000 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
4000000 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
4000000 usd
CY2023Q3 rxo Debt Instrument Face Amount Non Current
DebtInstrumentFaceAmountNonCurrent
459000000 usd
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
451000000 usd
CY2022Q4 rxo Debt Instrument Face Amount Non Current
DebtInstrumentFaceAmountNonCurrent
460000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
451000000 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
8000000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
9000000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
13000000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
96000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
96000000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116970000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115163000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116823000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115163000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2593000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116970000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115163000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119415000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115163000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2800000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000 shares

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
rxo-20230930_cal.xml Edgar Link unprocessable
rxo-20230930_def.xml Edgar Link unprocessable
0001929561-23-000093-index-headers.html Edgar Link pending
0001929561-23-000093-index.html Edgar Link pending
0001929561-23-000093.txt Edgar Link pending
0001929561-23-000093-xbrl.zip Edgar Link pending
ex101-rxoxincrementalamend.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rxo-20230930.htm Edgar Link pending
rxo-20230930.xsd Edgar Link pending
rxo-20230930_g1.jpg Edgar Link pending
rxo2023q310-qexx311.htm Edgar Link pending
rxo2023q310-qexx312.htm Edgar Link pending
rxo2023q310-qexx321.htm Edgar Link pending
rxo2023q310-qexx322.htm Edgar Link pending
Show.js Edgar Link pending
rxo-20230930_lab.xml Edgar Link unprocessable
rxo-20230930_pre.xml Edgar Link unprocessable
rxo-20230930_htm.xml Edgar Link completed